<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89E6D9CB-DAF8-40A2-A9EF-B330A5A7FC24"><gtr:id>89E6D9CB-DAF8-40A2-A9EF-B330A5A7FC24</gtr:id><gtr:name>Open University</gtr:name><gtr:address><gtr:line1>Walton Hall</gtr:line1><gtr:line2>Walton</gtr:line2><gtr:line4>Milton Keynes</gtr:line4><gtr:line5>Buckinghamshire</gtr:line5><gtr:postCode>MK7 6AA</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:department>Neurosciences</gtr:department><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89E6D9CB-DAF8-40A2-A9EF-B330A5A7FC24"><gtr:id>89E6D9CB-DAF8-40A2-A9EF-B330A5A7FC24</gtr:id><gtr:name>Open University</gtr:name><gtr:address><gtr:line1>Walton Hall</gtr:line1><gtr:line2>Walton</gtr:line2><gtr:line4>Milton Keynes</gtr:line4><gtr:line5>Buckinghamshire</gtr:line5><gtr:postCode>MK7 6AA</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CAFFB86F-3BEB-4EC4-9430-C6E9BB7CFD55"><gtr:id>CAFFB86F-3BEB-4EC4-9430-C6E9BB7CFD55</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>B</gtr:otherNames><gtr:surname>Wharton</gtr:surname><gtr:orcidId>0000-0003-2785-333X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8A92553D-822E-4045-823C-9C8CCA624CD1"><gtr:id>8A92553D-822E-4045-823C-9C8CCA624CD1</gtr:id><gtr:firstName>Magnus</gtr:firstName><gtr:surname>Rattray</gtr:surname><gtr:orcidId>0000-0001-8196-5565</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6D96679F-7B87-4095-8643-EDEC89A16D03"><gtr:id>6D96679F-7B87-4095-8643-EDEC89A16D03</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Geoffrey</gtr:otherNames><gtr:surname>Ince</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E3406FFA-68B6-49BB-A34C-5A9008DA9B5A"><gtr:id>E3406FFA-68B6-49BB-A34C-5A9008DA9B5A</gtr:id><gtr:firstName>Pamela</gtr:firstName><gtr:otherNames>Jean</gtr:otherNames><gtr:surname>Shaw</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/40A44CDB-A76E-45FA-A53A-B0100BCDD5B6"><gtr:id>40A44CDB-A76E-45FA-A53A-B0100BCDD5B6</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Roy</gtr:otherNames><gtr:surname>Heath</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/83FB2515-9680-4697-815B-398F03B71192"><gtr:id>83FB2515-9680-4697-815B-398F03B71192</gtr:id><gtr:firstName>Fiona</gtr:firstName><gtr:otherNames>Elaine</gtr:otherNames><gtr:surname>Matthews</gtr:surname><gtr:orcidId>0000-0002-1728-2388</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/09717709-C72F-4D1D-A890-7310F654D410"><gtr:id>09717709-C72F-4D1D-A890-7310F654D410</gtr:id><gtr:firstName>Carol</gtr:firstName><gtr:surname>Brayne</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FJ004308%2F1"><gtr:id>BA099818-9486-4D7A-95DD-0BAB08884796</gtr:id><gtr:title>Oxidative DNA Damage and Transcriptional Impairment in Brain Ageing as an Early Contributor to Cognitive Impairment</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/J004308/1</gtr:grantReference><gtr:abstractText>With our ageing population, dementia is an increasing problem for individuals and their families and for the provision of care by society as a whole. There is an urgent need therefore to understand contributors to decline in brain function and to define potential new avenues for therapies, both to delay the progression of dementia and to delay its onset, which will have a major effect on dementia prevalence in the population. Most studies of dementia have been based on comparisons of individuals with established dementia to those with no dementia, and a major focus has been on Alzheimer's disease (AD), the commonest cause of dementia. However, this does not accurately reflect the situation in a population setting. The MRC Cognitive Function and Ageing Study (CFAS), a population-representative study, has shown an overlap in AD pathology between demented and non-demented individuals that increases at the oldest ages, so there is a need to define the role of other contributors to dementia. Oxidative stress has been shown to be associated with neurodegenerative diseases, and can damage a variety of molecules in cells, including DNA, which makes up genes and encodes cell proteins. Our studies have shown that, in the elderly population, high levels of DNA oxidative damage can occur in some individuals with little or no AD pathology, suggesting that it may contribute to dementia independently of AD. The purpose of this project is to determine DNA oxidative damage in the brain in the population and its relationship to dementia and the progression of AD. Using methods that allow us to analyse overall changes in the expression of genes within cells, we will then determine how oxidative DNA damage affects the cellular pathways of nerve cells in both human brain tissue and an experimental cell culture model. These studies will provide the link between oxidative damage and the decline in nerve cell function and open up novel avenues for research studies into mechanisms of dementia and potential treatments.</gtr:abstractText><gtr:technicalSummary>Oxidative stress is important in brain ageing and Alzheimer's disease (AD) but the relationship to cellular dysfunction and AD progression remains unclear. In a population-representative autopsy-brain sample from the MRC Cognitive Function and Ageing Study (CFAS), we have shown that oxidative stress and DNA damage occur in some individuals with little AD-pathology, suggesting that oxidative stress contributes to cognitive decline by promoting neuronal dysfunction in some individuals independently of AD. AD pathology does not explain all of dementia in a population setting, particularly in the oldest individuals and current approaches based on removing AD molecular pathology have had limited success, suggesting an urgent need to understand the role of &amp;quot;non-classical&amp;quot; cellular pathologies. We propose that chronic oxidative DNA damage may impair neuronal function by altering the neuronal transcriptome, by down-regulation of transcription and by induction of senescence mechanisms. At a population level we propose that neuronal dysfunction due to oxidative DNA damage explains a proportion of dementia, especially in the oldest old. We plan to determine the variation in oxidative DNA damage, particularly in individuals in the population without AD using the CFAS population-neuropathology cohort. We will determine the effect of oxidative DNA damage on the neuron in both CFAS and in a neuronal culture system and using markers of senescence and microarray gene-expression analysis to determine the effect on transcription. Bioinformatics approaches will allow determination of the effect of chronic oxidative stress on cellular pathways, whist time-course analysis in the cells will allow determination of how the neuronal response changes. This study will define the contribution of oxidative stress to dementia at a population level and identify altered cellular pathways reflecting neuronal injury and adaptation response that will lead to novel avenues for investigation.</gtr:technicalSummary><gtr:potentialImpactText>At present the focus of dementia research is on classical pathological lesions, such as neurofibrillary tangles and plaques and the associated abnormal proteins, beta-amyloid and tau. These remain important targets, but the fact that these lesions do not explain all dementia in a population setting and the lack of success of current therapies that target these proteins demonstrate a need to understand non-classical markers. This project will help to define the role of oxidative stress in age-related cognitive impairment in a population setting and the cellular link between oxidative neuronal damage and neuronal dysfunction. This may aid in explaining the deficit in pathological models of dementia, especially in the oldest old, the demographic group in which AD pathology is most poorly predictive of dementia and in which most cases of dementia occur. Understanding oxidative stress and how it relates to the progression of AD pathology is itself important to targeting this therapeutically and in preventive measures to reduce cognitive impairment in a population setting. Defining how neuronal cell pathways respond to oxidative stress will identify potential novel avenues for therapies targeted against specific pathways and for biomarker development. In addition to the results from this work, the study will generate data from which novel specific hypotheses will be developed for further functional studies. The population-based data on the CFAS cohort will be archived in the CFAS database. This will be available to future studies in CFAS; the availability of this rich, population-representative set of pathological and molecular data is one of the strengths of CFAS. In addition, the bioinformatics data on both the neurons laser-captured from CFAS cases and form the cell culture work will be deposited in an on-line gene expression database, further adding value to the study by making this extensive data available for bioinformatics studies by other workers.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>413514</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Open University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Role of microRNAs in ageing at the blood brain barrier</gtr:description><gtr:id>03B0F776-2B94-4B0C-A6B1-5853C3470162</gtr:id><gtr:impact>New grant funding from BBSRC to both centres</gtr:impact><gtr:outcomeId>QrbpDAzA55S-1</gtr:outcomeId><gtr:partnerContribution>Complementary studies form our collaborators at the OU, led by Dr Ignacio Romero, focus on experimental work</gtr:partnerContribution><gtr:piContribution>Joint two centre grant. Our centre focuses on human tissue based studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Journal promotion of one of our papers</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0DAFB00E-5CC2-4104-955C-89AF4496FE1E</gtr:id><gtr:impact>Promotion of our article on neuronal DNA damage response associated signalling changes.. by the publisher, Wiley to coincide with National Alzheimer's Awareness month.</gtr:impact><gtr:outcomeId>58aead40751cc0.81593092</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SITraN Open Day  July 2014</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EF3C4A28-DE05-45BA-9A41-37DFE6482B39</gtr:id><gtr:impact>Open day at SITraN allowing lay persons to look at work on neurodegeneration, in including dementia in Sheffield.

Public information and interest in donations</gtr:impact><gtr:outcomeId>5435585a450cb9.40996591</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio interview by Dr Claire Garwood on our group's work, BBC Radio Sheffield</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8E3BFD55-14B9-41A2-955A-1EDC202BFAEB</gtr:id><gtr:impact>Informed public via radio

Not formally assessed.</gtr:impact><gtr:outcomeId>554a2eb9488145.61391347</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dr Garwood presentation at Festival of Science and Engineering Your amazing brain</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6E4A257C-29A0-4B48-867E-9193688CCAE5</gtr:id><gtr:impact>Stimulated interest in children

Questions</gtr:impact><gtr:outcomeId>554a316a14c367.08099982</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alzheimer Society Local Group Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5A8FE9E5-FDB9-4C90-A1F2-2E83155AEE69</gtr:id><gtr:impact>Member of out group spoke about our dementia research predominantly to dementia support workers.

Better public information</gtr:impact><gtr:outcomeId>545cd6a7196c07.13557611</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit by Alzheimer's Society network volunteers</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1497613B-C2F4-4C5D-8DC2-CEE420E7055E</gtr:id><gtr:impact>Stephen Wharton Organised visit by Alzheimer's Society network volunteers. Nov 10 2015. 3 visitors - meet the group, 2 talks and lab tour.</gtr:impact><gtr:outcomeId>56d55f55393e85.61589135</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Short film about dementia research in Sheffield</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E10E1430-9387-4090-BEB1-A6480EB21C5C</gtr:id><gtr:impact>Claire Garwood received funding from the Engaged Curriculum to produce a short film about the broad range of dementia research at the University of Sheffield.</gtr:impact><gtr:outcomeId>56d55dd14973f6.83833594</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshops in primary schools</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6C69B4CE-5665-44BD-BA09-1462683C006D</gtr:id><gtr:impact>Claire Garwood, Laura Ratcliffe and Irina Villasenor. Sheffield Festival of Science and Engineering. 3 Half day workshops in local primary schools &amp;quot;Your Amazing Brain&amp;quot;.</gtr:impact><gtr:outcomeId>56d55e4ae44832.54537559</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Build up of DNA damage in nerve cells can lead to dementia.</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>98711890-B571-426E-95F5-39427B5C16DE</gtr:id><gtr:impact>Steve Wharton Press release on Sheffield University website (www.shef.ac.uk) 26 June 2015</gtr:impact><gtr:outcomeId>56d55ede12b8d6.98431577</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to Ignite Academy Event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5EF26F04-5837-4505-B241-F51826BCE6D5</gtr:id><gtr:impact>Talk given by member of our group &amp;quot;Astrocytes:Guardians of the Brain&amp;quot;

Better public information</gtr:impact><gtr:outcomeId>545cd7811c69a1.12690835</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker British Neuroscience Association Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>876047AE-A86B-47D8-893F-94030C240099</gtr:id><gtr:impact>Generate questions and discussion. Improved professional relationships that might lead to collaboration.

Communication both immediately after and by email</gtr:impact><gtr:outcomeId>554a306147e741.38016979</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hosted laboratory visit for lay guests of the ARUK</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3CC268E3-D85F-473A-AF1E-0843C36DE756</gtr:id><gtr:impact>Lay guests and potential donors to ARUK were informed of our work on astrocytes.

Unknown at present</gtr:impact><gtr:outcomeId>rqhZdpWPSSj</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog post</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BA755028-BFEA-4AF7-B52B-33111F066E02</gtr:id><gtr:impact>Release of blog post about our Alz Soc funded diabetes grant, written by the post doc.</gtr:impact><gtr:outcomeId>58aeabe8998a79.81563903</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>225718</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Alzheimer?s Society</gtr:fundingOrg><gtr:id>B33C1AA2-81D4-4396-9E1F-8D8CDB5D435E</gtr:id><gtr:outcomeId>58aea8206b9214.45801259</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BNS Small Grant Scheme - Oxidative damage to nucleic acids in MND</gtr:description><gtr:fundingOrg>British Neuropathological Society</gtr:fundingOrg><gtr:id>935CB3EF-DBCE-4998-A12D-4D66E668124D</gtr:id><gtr:outcomeId>eesfVaS2g9U</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>84450</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Scholarship</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>38AF6697-BF42-447B-A985-DFD50B584A2B</gtr:id><gtr:outcomeId>58aea9b53cfbf1.37273855</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>87900</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ARUK PhD Scholarship</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:fundingRef>ARUK PhD2016-1</gtr:fundingRef><gtr:id>9141E24C-C925-4BA6-8478-A5AF4FEB4621</gtr:id><gtr:outcomeId>58aea9464a0e09.36002289</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>237984</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Interdisciplinary research grant</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>9537BB01-1ACE-4E07-8AAF-117CC6A99D71</gtr:id><gtr:outcomeId>58aea7729ca787.65390804</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Gene expression data deposited in the Gene Expression Omnibus, accession number GSE66333</gtr:description><gtr:id>7CE2AF8A-A6D2-40B4-98F6-8679D77FE68C</gtr:id><gtr:impact>Availability of data to bioinformatics community.</gtr:impact><gtr:outcomeId>58aeaf12282b15.95130344</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Gene expression microarray data associated with neuronal DNA damage</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9D6212E9-FBF1-415A-AF52-3E25D6B7E441</gtr:id><gtr:title>Epidemiological pathology of Tau in the ageing brain: application of staging for neuropil threads (BrainNet Europe protocol) to the MRC cognitive function and ageing brain study.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff9861a37e6da193cfc1fb2aa8e788e"><gtr:id>9ff9861a37e6da193cfc1fb2aa8e788e</gtr:id><gtr:otherNames>Wharton SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56d55b9805d558.93137702</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF52E05B-56FD-4E5F-8EE6-B0465ABC57A2</gtr:id><gtr:title>Oxidative Glial Cell Damage Associated with White Matter Lesions in the Aging Human Brain.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/498bed82ae06288d048197db7cccb49b"><gtr:id>498bed82ae06288d048197db7cccb49b</gtr:id><gtr:otherNames>Al-Mashhadi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>545cd13d5d21f4.82227555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D06BE67F-0E7B-4DB7-9B7F-19395AB1ECD9</gtr:id><gtr:title>Mesial temporal astrocyte tau pathology in the MRC-CFAS ageing brain cohort.</gtr:title><gtr:parentPublicationTitle>Dementia and geriatric cognitive disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af01bcaabff4dfd4ac18896c34ef80bc"><gtr:id>af01bcaabff4dfd4ac18896c34ef80bc</gtr:id><gtr:otherNames>Lace G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1420-8008</gtr:issn><gtr:outcomeId>pm_13950_20_22868294</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E70FB80-389E-460C-90FE-03A88FF2A3FC</gtr:id><gtr:title>A reduced astrocyte response to ?-amyloid plaques in the ageing brain associates with cognitive impairment.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0932dcd014438629afa5aaa305271b53"><gtr:id>0932dcd014438629afa5aaa305271b53</gtr:id><gtr:otherNames>Mathur R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>554a2bd3c6d4e5.82406345</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03D08F7B-2AE3-4372-9C23-06BA44B0404E</gtr:id><gtr:title>A neuronal DNA damage response is detected at the earliest stages of Alzheimer's neuropathology and correlates with cognitive impairment in the Medical Research Council's Cognitive Function and Ageing Study ageing brain cohort.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd557a19ad80f4b45467d18ceaab3fe5"><gtr:id>bd557a19ad80f4b45467d18ceaab3fe5</gtr:id><gtr:otherNames>Simpson JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>554a2bd38fe164.01213873</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BF4F555-AF50-41C7-93BF-932794FA5F9A</gtr:id><gtr:title>Alpha-synuclein mRNA expression in oligodendrocytes in MSA.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a25a6988d5aadc65741d1b68af379f6"><gtr:id>1a25a6988d5aadc65741d1b68af379f6</gtr:id><gtr:otherNames>Asi YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>pm_13950_20_24590631</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>391AE4EB-8194-4C2F-8E37-4191C0163C52</gtr:id><gtr:title>Expression microdissection isolation of enriched cell populations from archival brain tissue.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caa37a8306b2d3dc965bab0b22677235"><gtr:id>caa37a8306b2d3dc965bab0b22677235</gtr:id><gtr:otherNames>Appleby-Mallinder C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn><gtr:outcomeId>58aea3b4b4a785.15154339</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4208B848-3EA9-4938-8EA3-B624B0282E37</gtr:id><gtr:title>Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG).</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8589a7315a7ba0fad1154b0030273cf"><gtr:id>c8589a7315a7ba0fad1154b0030273cf</gtr:id><gtr:otherNames>Kovacs GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>5a8a94558eea48.15467579</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8304A506-8381-472E-9153-974C6517979D</gtr:id><gtr:title>DNA damage response and senescence in endothelial cells of human cerebral cortex and relation to Alzheimer's neuropathology progression: a population-based study in the Medical Research Council Cognitive Function and Ageing Study (MRC-CFAS) cohort.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c58c64d02a3edc3d0ae27f66455b7e2"><gtr:id>6c58c64d02a3edc3d0ae27f66455b7e2</gtr:id><gtr:otherNames>Garwood CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>534d4c0ec94913.91435046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ABFE750-5F0F-4516-B2EA-C5E06E18BB82</gtr:id><gtr:title>Age-associated white matter lesions: the MRC Cognitive Function and Ageing Study.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff9861a37e6da193cfc1fb2aa8e788e"><gtr:id>9ff9861a37e6da193cfc1fb2aa8e788e</gtr:id><gtr:otherNames>Wharton SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>545cd2f88a3236.99407426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8929B2E1-4B8C-4173-B5BD-FDA3A4A326D9</gtr:id><gtr:title>Review: Neuropathology and behavioural features of transgenic murine models of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c679de2cf2c0e7f7c222a138822e12d8"><gtr:id>c679de2cf2c0e7f7c222a138822e12d8</gtr:id><gtr:otherNames>Ameen-Ali KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>5a8a9455ca6686.83926086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C557F332-DA05-49A7-A4D0-9DF87F34A493</gtr:id><gtr:title>Immuno-Laser-Capture Microdissection for the Isolation of Enriched Glial Populations from Frozen Post-Mortem Human Brain.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd557a19ad80f4b45467d18ceaab3fe5"><gtr:id>bd557a19ad80f4b45467d18ceaab3fe5</gtr:id><gtr:otherNames>Simpson JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>5a8a9455eeeda3.13245443</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47F665AB-C7CC-4E2D-A9EC-478B67C25CFE</gtr:id><gtr:title>A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70857d7918bb70a4eda7d19cf01c73c0"><gtr:id>70857d7918bb70a4eda7d19cf01c73c0</gtr:id><gtr:otherNames>Matthews FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58aea352a837c6.74650619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0739AC22-4008-417B-B712-9979A082A256</gtr:id><gtr:title>Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal Pathology.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e0a6b54e53a39c8c686adf737fd555c"><gtr:id>7e0a6b54e53a39c8c686adf737fd555c</gtr:id><gtr:otherNames>Stratmann K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>56d55b97cdd087.90590749</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07A8489F-80D4-40B2-8E57-70CDAFFE020F</gtr:id><gtr:title>Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors.</gtr:title><gtr:parentPublicationTitle>Molecular brain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c58c64d02a3edc3d0ae27f66455b7e2"><gtr:id>6c58c64d02a3edc3d0ae27f66455b7e2</gtr:id><gtr:otherNames>Garwood CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1756-6606</gtr:issn><gtr:outcomeId>554a2d53b99ec8.95338401</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41E56379-0C09-46A8-88F9-901E75A5A6C8</gtr:id><gtr:title>The nuclear retention of transcription factor FOXO3a correlates with a DNA damage response and increased glutamine synthetase expression by astrocytes suggesting a neuroprotective role in the ageing brain.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2a4c7ede55899808f1991361463fd09"><gtr:id>c2a4c7ede55899808f1991361463fd09</gtr:id><gtr:otherNames>Fluteau A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>5638cc3eb52e50.92372184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6C89A2C-DCD9-4FAB-B8CA-38D8DB93A588</gtr:id><gtr:title>Calcium dysregulation in relation to Alzheimer-type pathology in the ageing brain.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f57af54aaf68af39c7fb8a5b1854743"><gtr:id>1f57af54aaf68af39c7fb8a5b1854743</gtr:id><gtr:otherNames>Garwood C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>mXsT3ik2asx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84C98CCD-6FF0-49C5-859A-2C9E960F82C8</gtr:id><gtr:title>Neuronal DNA damage response-associated dysregulation of signalling pathways and cholesterol metabolism at the earliest stages of Alzheimer-type pathology.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd557a19ad80f4b45467d18ceaab3fe5"><gtr:id>bd557a19ad80f4b45467d18ceaab3fe5</gtr:id><gtr:otherNames>Simpson JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56d55b97a8a397.77529071</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J004308/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>